Community acquired pneumonia

Authors

  • Juan A. Salas-Lopez Hospital Nacional Dos de Mayo
  • Félix K. Llanos-Tejada Universidad Ricardo Palma
  • Edwin H. Herrera-Flores Hospital Nacional Arzobispo Loayza
  • María Venero-Cáceres Hospital Nacional Arzobispo Loayza
  • Carlos A. Saavedra-Leveau Universidad Nacional Mayor de San Marcos

DOI:

https://doi.org/10.33734/diagnostico.v58i4.173

Keywords:

Pneumonia, community pneumonia, risk factors, treatment

Abstract

Community-acquired pneumonia is an infectious disease of the lung parenchyma, prevalent in our country with partial identification of etiological agents. It is the result of the interaction of the inflammatory process and infectious agents, with impact on the respiratory physiology with clearly identified risk factors. The diagnosis is based on clinical and radiological aspects. It requires a rational use of antibiotics, in an era of bacterial resistance. In the present symposium, definition and epidemiology are considered, with emphasis on national microbiology. In the diagnosis section, it focuses on clinical, radiological, etiological and laboratory tests. In therapy it is based on 3 aspects: degree of severity, identification of risk factors for specific agents and resistance. Control during the evolution of the disease and complications are also
evaluated. Emphasis is placed on preventive aspects. 

Downloads

Download data is not yet available.

Metrics

Metrics Loading ...

Published

09-02-2020

How to Cite

1.
Salas-Lopez JA, Llanos-Tejada FK, Herrera-Flores EH, Venero-Cáceres M, Saavedra-Leveau CA. Community acquired pneumonia. diagnostico [nternet]. 2020 Feb. 9 [cited 2024 Dec. 4];58(4):181-5. vailable from: https://revistadiagnostico.fihu.org.pe/index.php/diagnostico/article/view/173

Issue

Section

Symposium

Most read articles by the same author(s)